#pharmaceuticals

Eli Lilly's Weight-Loss Pill Gets First European Approval in Britain

The MHRA authorised orforglipron for obesity and type 2 diabetes, but NHS access hinges on a NICE decision due in November.

UK regulator approves Lilly's weight-loss pill

The MHRA clearance for orforglipron, branded Foundayo, covers both obesity and type 2 diabetes and sets up a direct clash with Novo Nordisk’s oral semaglutide in Britain.

FDA Approves Moderna's mRNA Flu Vaccine

The decision marks the first U.S. approval of a messenger RNA-based vaccine for seasonal influenza, following a 9-0 advisory panel vote in June.

Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising